Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Market Cap	23.30B
Revenue (ttm)	13.93B
Net Income (ttm)	2.20B
Shares Out	4.57B
EPS (ttm)	0.48
PE Ratio	10.65
Forward PE	9.16
Dividend	0.23 (4.52%)
Ex-Dividend Date	Oct 18, 2024

Volume	67,307,554
Average Volume	11,387,574
Open	5.18
Previous Close	5.10
Day's Range	5.12 - 5.94
52-Week Range	3.60 - 6.54
Beta	0.55
RSI	67.01
Earnings Date	Mar 27, 2025

About HKG:1066

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers single use medical consumables and materials, including infusion sets, syringes, blood bags and blood component segregators consumable, blood sampling products, prefilled syringes for...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2000
• Employees: 12,519
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1066

Financial Performance

In 2024, HKG:1066's revenue was 13.09 billion, a decrease of -1.08% compared to the previous year's 13.23 billion. Earnings were 2.07 billion, an increase of 3.24%.

Financial numbers in CNY